A Randomized, Double-Blind, Placebo Controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of ABBV-0805 in Patients with Parkinson's Disease
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
AbbVie Inc.
Start Date
November 13, 2019
End Date
November 12, 2020
Administered By
Neurology, Movement Disorders
Awarded By
AbbVie Inc.
Start Date
November 13, 2019
End Date
November 12, 2020